TAO / USD1

AVAX / U

FOGO / USDC

FOGO / USDT

ONT / TRY

WIF / IDR

ONT / USDT

ONT / USDC

FOGO / TRY

CFG / USDC

D / TRY

D / USDT

SCRT / USDT

MMT / TRY

MMT / USDT

MMT / USDC

BROCCOLI714 / USDT

币安人生 / USDT

BROCCOLI714 / USDC

币安人生 / USDC

5PAISA CAPITAL LTD

KREBS BIOCHEMICALS & IND

SAKUMA EXPORTS LIMITED

AKSHAR SPINTEX LIMITED

STL GLOBAL LIMITED

JEYYAM GLOBAL FOODS LTD

CHETANA EDUCATION LIMITED

VISAGAR POLYTEX LTD

ENSER COMMUNICATIONS LTD

BOMBAY SUPER HYBRID SEEDS

SUNREST LIFESCIENCE LTD

SHANTHALA FMCG PRODUCTS L

AMIR CHAND JAG KUM (E) L

SUPREME FACILITY MGMT LTD

BLUE WATER LOGISTICS LTD

MAHA RASHTRA APEX CORPOR

HARIOM PIPE INDUSTRIES L

TSC INDIA LIMITED

PENTAGON RUBBER LIMITED

INFOMEDIA PRESS LIMITED

Click here to get full coverage on Tatva Chintan Pharma Chem Ltd Opens 5.57% Lower as Technicals Signal Continued Downside - Markets Mojo

Tatva Chintan Pharma Chem Ltd Opens 5.57% Lower as Technicals Signal Continued Downside  Markets Mojo

Tatva Chintan Pharma Chem Ltd Opens 5.57% Lower as Technicals Signal Continued Downside - Markets Mojo

Click here to get full coverage on Tatva Cafe serves vegetarian Indian cuisine in Ellisville - saucemagazine.com

Tatva Cafe serves vegetarian Indian cuisine in Ellisville  saucemagazine.com

Tatva Cafe serves vegetarian Indian cuisine in Ellisville - saucemagazine.com

Click here to get full coverage on Tatva Chintan Plans Virtual Investor Meeting With OysterRock Capital - TipRanks

Tatva Chintan Plans Virtual Investor Meeting With OysterRock Capital  TipRanks

Tatva Chintan Plans Virtual Investor Meeting With OysterRock Capital - TipRanks

Click here to get full coverage on Gas Supply Regulation Disclosure; Tatva Chintan Shares Slip 0.90% - HDFC Sky

Gas Supply Regulation Disclosure; Tatva Chintan Shares Slip 0.90%  HDFC Sky

Gas Supply Regulation Disclosure; Tatva Chintan Shares Slip 0.90% - HDFC Sky

Click here to get full coverage on Tatva Chintan Pharma Chem Limited Just Beat EPS By 44%: Here's What Analysts Think Will Happen Next - simplywall.st

Tatva Chintan Pharma Chem Limited Just Beat EPS By 44%: Here's What Analysts Think Will Happen Next  simplywall.st

Tatva Chintan Pharma Chem Limited Just Beat EPS By 44%: Here's What Analysts Think Will Happen Next - simplywall.st

Click here to get full coverage on Tatva Chintan Faces New Gas Supply Curbs and Pricing Regime Under Government Order - TipRanks

Tatva Chintan Faces New Gas Supply Curbs and Pricing Regime Under Government Order  TipRanks

Tatva Chintan Faces New Gas Supply Curbs and Pricing Regime Under Government Order - TipRanks

Click here to get full coverage on Mukul Agrawal portfolio: What's driving Tatva Chintan to zoom 50% in 1 mth - business-standard.com

Mukul Agrawal portfolio: What's driving Tatva Chintan to zoom 50% in 1 mth  business-standard.com

Mukul Agrawal portfolio: What's driving Tatva Chintan to zoom 50% in 1 mth - business-standard.com

Click here to get full coverage on Tatva Legal Hyderabad rebrands as TLH Advocates & Solicitors - Law.asia

Tatva Legal Hyderabad rebrands as TLH Advocates & Solicitors  Law.asia

Tatva Legal Hyderabad rebrands as TLH Advocates & Solicitors - Law.asia

Click here to get full coverage on Goldman Sachs’ India bets slide in FY26; 5 stocks crash over 50% but one turns multibagger - The Economic Times

Goldman Sachs’ India bets slide in FY26; 5 stocks crash over 50% but one turns multibagger  The Economic Times

Goldman Sachs’ India bets slide in FY26; 5 stocks crash over 50% but one turns multibagger - The Economic Times

Click here to get full coverage on Tatva Chintan Pharma Chem posts consolidated Q3 FY26 at Rs. 15.16 Cr - Indian Pharma Post

Tatva Chintan Pharma Chem posts consolidated Q3 FY26 at Rs. 15.16 Cr  Indian Pharma Post

Tatva Chintan Pharma Chem posts consolidated Q3 FY26 at Rs. 15.16 Cr - Indian Pharma Post

Click here to get full coverage on Tatva Chintan Pharma Chem Ltd Forms Death Cross, Signalling Bearish Trend Ahead - Markets Mojo

Tatva Chintan Pharma Chem Ltd Forms Death Cross, Signalling Bearish Trend Ahead  Markets Mojo

Tatva Chintan Pharma Chem Ltd Forms Death Cross, Signalling Bearish Trend Ahead - Markets Mojo

Click here to get full coverage on Ajay Mansukhlal Patel to Acquire 7,15,345 Equity Shares in Tatva Chintan Pharma Chem Through HUF Dissolution - scanx.trade

Ajay Mansukhlal Patel to Acquire 7,15,345 Equity Shares in Tatva Chintan Pharma Chem Through HUF Dissolution  scanx.trade

Ajay Mansukhlal Patel to Acquire 7,15,345 Equity Shares in Tatva Chintan Pharma Chem Through HUF Dissolution - scanx.trade

Click here to get full coverage on Tatva Chintan Publishes Q3 FY26 Earnings Call Transcript for Investor Access - TipRanks

Tatva Chintan Publishes Q3 FY26 Earnings Call Transcript for Investor Access  TipRanks

Tatva Chintan Publishes Q3 FY26 Earnings Call Transcript for Investor Access - TipRanks

Click here to get full coverage on Market Participants Recognise Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Revenues Pushing Shares 34% Higher - simplywall.st

Market Participants Recognise Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Revenues Pushing Shares 34% Higher  simplywall.st

Market Participants Recognise Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Revenues Pushing Shares 34% Higher - simplywall.st

Click here to get full coverage on Tatva Chintan Pharma Chem Ltd is Rated Hold - Markets Mojo

Tatva Chintan Pharma Chem Ltd is Rated Hold  Markets Mojo

Tatva Chintan Pharma Chem Ltd is Rated Hold - Markets Mojo

Click here to get full coverage on Tatva Chintan Schedules Compliant Virtual Investor Meet on 16 March 2026 - TipRanks

Tatva Chintan Schedules Compliant Virtual Investor Meet on 16 March 2026  TipRanks

Tatva Chintan Schedules Compliant Virtual Investor Meet on 16 March 2026 - TipRanks

Click here to get full coverage on Tatva Chintan Pharma Chem Limited's (NSE:TATVA) most bullish insider is Senior Key Executive Ajaykumar Patel, and their holdings value went up by 10% last week - simplywall.st

Tatva Chintan Pharma Chem Limited's (NSE:TATVA) most bullish insider is Senior Key Executive Ajaykumar Patel, and their holdings value went up by 10% last week  simplywall.st

Tatva Chintan Pharma Chem Limited's (NSE:TATVA) most bullish insider is Senior Key Executive Ajaykumar Patel, and their holdings value went up by 10% last week - simplywall.st

Click here to get full coverage on Tatva Chintan Pharma Chem Ltd Technical Momentum Shifts Amid Mixed Market Signals - Markets Mojo

Tatva Chintan Pharma Chem Ltd Technical Momentum Shifts Amid Mixed Market Signals  Markets Mojo

Tatva Chintan Pharma Chem Ltd Technical Momentum Shifts Amid Mixed Market Signals - Markets Mojo

Click here to get full coverage on Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue? - simplywall.st

Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?  simplywall.st

Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue? - simplywall.st

Click here to get full coverage on Tatva Chintan Pharma Chem Limited Schedules Virtual Investor Meeting with Emerge Capital for March 18, 2026 - scanx.trade

Tatva Chintan Pharma Chem Limited Schedules Virtual Investor Meeting with Emerge Capital for March 18, 2026  scanx.trade

Tatva Chintan Pharma Chem Limited Schedules Virtual Investor Meeting with Emerge Capital for March 18, 2026 - scanx.trade

Click here to get full coverage on Tatva Chintan Pharma Chem Ltd Faces Technical Momentum Shift Amid Mixed Market Signals - Markets Mojo

Tatva Chintan Pharma Chem Ltd Faces Technical Momentum Shift Amid Mixed Market Signals  Markets Mojo

Tatva Chintan Pharma Chem Ltd Faces Technical Momentum Shift Amid Mixed Market Signals - Markets Mojo

Click here to get full coverage on Tatva Chintan Consolidated December 2025 Net Sales at Rs 131.33 crore, up 52.9% Y-o-Y - Moneycontrol.com

Tatva Chintan Consolidated December 2025 Net Sales at Rs 131.33 crore, up 52.9% Y-o-Y  Moneycontrol.com

Tatva Chintan Consolidated December 2025 Net Sales at Rs 131.33 crore, up 52.9% Y-o-Y - Moneycontrol.com

Click here to get full coverage on Tatva Chintan Pharma Chem Limited Schedules Investor Meeting with OysterRock Capital for March 24, 2026 - scanx.trade

Tatva Chintan Pharma Chem Limited Schedules Investor Meeting with OysterRock Capital for March 24, 2026  scanx.trade

Tatva Chintan Pharma Chem Limited Schedules Investor Meeting with OysterRock Capital for March 24, 2026 - scanx.trade

Click here to get full coverage on Tatva Chintan Pharma Chem Ltd Hits Intraday Low Amid Price Pressure - Markets Mojo

Tatva Chintan Pharma Chem Ltd Hits Intraday Low Amid Price Pressure  Markets Mojo

Tatva Chintan Pharma Chem Ltd Hits Intraday Low Amid Price Pressure - Markets Mojo

Click here to get full coverage on Tatva Chintan Faces 80% Gas Cut, New Pricing From March 2026 - Whalesbook

Tatva Chintan Faces 80% Gas Cut, New Pricing From March 2026  Whalesbook

Tatva Chintan Faces 80% Gas Cut, New Pricing From March 2026 - Whalesbook

Click here to get full coverage on Reduce Tatva Chintan Pharma Chem; target of Rs 1380: Deven Choksey - Moneycontrol.com

Reduce Tatva Chintan Pharma Chem; target of Rs 1380: Deven Choksey  Moneycontrol.com

Reduce Tatva Chintan Pharma Chem; target of Rs 1380: Deven Choksey - Moneycontrol.com

Click here to get full coverage on Tatva Chintan Pharma Chem Reports Strong Q3 FY26 Results with Revenue Growth of 52.9% - scanx.trade

Tatva Chintan Pharma Chem Reports Strong Q3 FY26 Results with Revenue Growth of 52.9%  scanx.trade

Tatva Chintan Pharma Chem Reports Strong Q3 FY26 Results with Revenue Growth of 52.9% - scanx.trade

Click here to get full coverage on Tatva Chintan Pharma Chem Targets 20-30% Revenue Growth for FY26 and FY27 - scanx.trade

Tatva Chintan Pharma Chem Targets 20-30% Revenue Growth for FY26 and FY27  scanx.trade

Tatva Chintan Pharma Chem Targets 20-30% Revenue Growth for FY26 and FY27 - scanx.trade

Click here to get full coverage on Mona-Pali's Paanch Tatva | India News - Hindustan Times

Mona-Pali's Paanch Tatva | India News  Hindustan Times

Mona-Pali's Paanch Tatva | India News - Hindustan Times

Click here to get full coverage on Tatva Chintan Pharma Chem Ltd Technical Momentum Shifts Amid Market Volatility - Markets Mojo

Tatva Chintan Pharma Chem Ltd Technical Momentum Shifts Amid Market Volatility  Markets Mojo

Tatva Chintan Pharma Chem Ltd Technical Momentum Shifts Amid Market Volatility - Markets Mojo

Click here to get full coverage on Tatva Chintan Pharma Chem - Q3 Profit Boom: 10 smallcaps surge up to 150% in a year, 3 become multibaggers - The Economic Times

Tatva Chintan Pharma Chem - Q3 Profit Boom: 10 smallcaps surge up to 150% in a year, 3 become multibaggers  The Economic Times

Tatva Chintan Pharma Chem - Q3 Profit Boom: 10 smallcaps surge up to 150% in a year, 3 become multibaggers - The Economic Times

Click here to get full coverage on Tatva Chintan Pharma: Faces 80% Gas Supply Limit Due To Government Rules; Company Seeking Other Fuel Options - scanx.trade

Tatva Chintan Pharma: Faces 80% Gas Supply Limit Due To Government Rules; Company Seeking Other Fuel Options  scanx.trade

Tatva Chintan Pharma: Faces 80% Gas Supply Limit Due To Government Rules; Company Seeking Other Fuel Options - scanx.trade

Click here to get full coverage on Tatva Chintan Pharma Chem Investor Meeting: OysterRock Capital se **March 24, 2026** ko hogi baat - Whalesbook

Tatva Chintan Pharma Chem Investor Meeting: OysterRock Capital se **March 24, 2026** ko hogi baat  Whalesbook

Tatva Chintan Pharma Chem Investor Meeting: OysterRock Capital se **March 24, 2026** ko hogi baat - Whalesbook

Click here to get full coverage on Mukul Agrawal’s winning picks: 4 stocks turn multibaggers in FY26; fresh Q3 additions revealed - The Economic Times

Mukul Agrawal’s winning picks: 4 stocks turn multibaggers in FY26; fresh Q3 additions revealed  The Economic Times

Mukul Agrawal’s winning picks: 4 stocks turn multibaggers in FY26; fresh Q3 additions revealed - The Economic Times

Click here to get full coverage on Buy Tatva Chintan Pharma Chem; target of Rs 1955: ICICI Securities - Moneycontrol.com

Buy Tatva Chintan Pharma Chem; target of Rs 1955: ICICI Securities  Moneycontrol.com

Buy Tatva Chintan Pharma Chem; target of Rs 1955: ICICI Securities - Moneycontrol.com

Click here to get full coverage on TLH expands disputes offerings with senior in-house hire - ETLegalWorld.com

TLH expands disputes offerings with senior in-house hire  ETLegalWorld.com

TLH expands disputes offerings with senior in-house hire - ETLegalWorld.com

Click here to get full coverage on Tatva Legal Hyderabad rebrands as TLH, Advocates & Solicitors - BW Legal World

Tatva Legal Hyderabad rebrands as TLH, Advocates & Solicitors  BW Legal World

Tatva Legal Hyderabad rebrands as TLH, Advocates & Solicitors - BW Legal World

Click here to get full coverage on Tatva Chintan Pharma Chem Projects ₹200-250 Crores Revenue from New Intermediates by 2027 - scanx.trade

Tatva Chintan Pharma Chem Projects ₹200-250 Crores Revenue from New Intermediates by 2027  scanx.trade

Tatva Chintan Pharma Chem Projects ₹200-250 Crores Revenue from New Intermediates by 2027 - scanx.trade

Click here to get full coverage on Here's why Tatva Chintan Pharma shares surged 20% on Friday in a weak market - CNBC TV18

Here's why Tatva Chintan Pharma shares surged 20% on Friday in a weak market  CNBC TV18

Here's why Tatva Chintan Pharma shares surged 20% on Friday in a weak market - CNBC TV18

Click here to get full coverage on Tatva Chintan Pharma Chem: Analytical Perspective Shift Amid Mixed Financial and Technical Signals - Markets Mojo

Tatva Chintan Pharma Chem: Analytical Perspective Shift Amid Mixed Financial and Technical Signals  Markets Mojo

Tatva Chintan Pharma Chem: Analytical Perspective Shift Amid Mixed Financial and Technical Signals - Markets Mojo

Click here to get full coverage on Shashank Nimkar on Earth Tatva: Turning Ceramic Waste Into Sustainable Design - The Hindu

Shashank Nimkar on Earth Tatva: Turning Ceramic Waste Into Sustainable Design  The Hindu

Shashank Nimkar on Earth Tatva: Turning Ceramic Waste Into Sustainable Design - The Hindu

Click here to get full coverage on Tatva Chintan Pharma Chem Reports Robust Q2 Turnaround with 99.2 Million Rupees Net Profit - scanx.trade

Tatva Chintan Pharma Chem Reports Robust Q2 Turnaround with 99.2 Million Rupees Net Profit  scanx.trade

Tatva Chintan Pharma Chem Reports Robust Q2 Turnaround with 99.2 Million Rupees Net Profit - scanx.trade

Click here to get full coverage on Tatva Chintan Pharma Chem Projects ₹850-900 Crores Revenue from Current Capacity - scanx.trade

Tatva Chintan Pharma Chem Projects ₹850-900 Crores Revenue from Current Capacity  scanx.trade

Tatva Chintan Pharma Chem Projects ₹850-900 Crores Revenue from Current Capacity - scanx.trade

Click here to get full coverage on Tatva Chintan Pharma Chem Targets 20-22% EBITDA Margins by FY27 Through Enhanced Plant Utilization - scanx.trade

Tatva Chintan Pharma Chem Targets 20-22% EBITDA Margins by FY27 Through Enhanced Plant Utilization  scanx.trade

Tatva Chintan Pharma Chem Targets 20-22% EBITDA Margins by FY27 Through Enhanced Plant Utilization - scanx.trade

Click here to get full coverage on Tatva Chintan Pharma Chem Ltd Sees Mixed Technical Signals Amid Mildly Bullish Momentum - Markets Mojo

Tatva Chintan Pharma Chem Ltd Sees Mixed Technical Signals Amid Mildly Bullish Momentum  Markets Mojo

Tatva Chintan Pharma Chem Ltd Sees Mixed Technical Signals Amid Mildly Bullish Momentum - Markets Mojo

Click here to get full coverage on Excentia Tatva Phase 2 coming up in Dehradun - Construction Week India

Excentia Tatva Phase 2 coming up in Dehradun  Construction Week India

Excentia Tatva Phase 2 coming up in Dehradun - Construction Week India

Click here to get full coverage on From Mr World to Restaurateur: Rohit Khandelwal's Tryst with Business! - femina.in

From Mr World to Restaurateur: Rohit Khandelwal's Tryst with Business!  femina.in

From Mr World to Restaurateur: Rohit Khandelwal's Tryst with Business! - femina.in

Click here to get full coverage on Tatva Chintan Pharma Chem Share Price Jumps 12% As Mukul Agrawal Picks Stake - Samco

Tatva Chintan Pharma Chem Share Price Jumps 12% As Mukul Agrawal Picks Stake  Samco

Tatva Chintan Pharma Chem Share Price Jumps 12% As Mukul Agrawal Picks Stake - Samco

Click here to get full coverage on Tatva Chintan Pharma Chem Ltd. Experiences Revision in Stock Evaluation Amid Strong Financial Growth - Markets Mojo

Tatva Chintan Pharma Chem Ltd. Experiences Revision in Stock Evaluation Amid Strong Financial Growth  Markets Mojo

Tatva Chintan Pharma Chem Ltd. Experiences Revision in Stock Evaluation Amid Strong Financial Growth - Markets Mojo

Click here to get full coverage on Tatva Chintan Pharma Chem Shows Bullish Momentum Amid Technical Shifts - Markets Mojo

Tatva Chintan Pharma Chem Shows Bullish Momentum Amid Technical Shifts  Markets Mojo

Tatva Chintan Pharma Chem Shows Bullish Momentum Amid Technical Shifts - Markets Mojo

Click here to get full coverage on Tatva Chintan Pharma Files SEBI Takeover Disclosure for Promoter Share Transfer - scanx.trade

Tatva Chintan Pharma Files SEBI Takeover Disclosure for Promoter Share Transfer  scanx.trade

Tatva Chintan Pharma Files SEBI Takeover Disclosure for Promoter Share Transfer - scanx.trade

Click here to get full coverage on Tatva Chintan Pharma Chem Invests Rs 4 Crore in Green Energy Project for Captive Power - scanx.trade

Tatva Chintan Pharma Chem Invests Rs 4 Crore in Green Energy Project for Captive Power  scanx.trade

Tatva Chintan Pharma Chem Invests Rs 4 Crore in Green Energy Project for Captive Power - scanx.trade

Click here to get full coverage on Mukul Agrawal picks 1.28% stake in this underperforming stock, drives 14% surge - The Economic Times

Mukul Agrawal picks 1.28% stake in this underperforming stock, drives 14% surge  The Economic Times

Mukul Agrawal picks 1.28% stake in this underperforming stock, drives 14% surge - The Economic Times

Click here to get full coverage on Tatva Chintan Pharma Chem - Goldman Sachs India portfolio slips, but 5 stocks rally 50-100% in 5 months - The Economic Times

Tatva Chintan Pharma Chem - Goldman Sachs India portfolio slips, but 5 stocks rally 50-100% in 5 months  The Economic Times

TATVA

Price Chart

Key Statistics

Technicals

About TATVA

Latest News

Tatva Chintan Pharma Chem Ltd Opens 5.57% Lower as Technicals Signal Continued Downside - Markets Mojo

Tatva Cafe serves vegetarian Indian cuisine in Ellisville - saucemagazine.com

Tatva Chintan Plans Virtual Investor Meeting With OysterRock Capital - TipRanks

Advanced Charts

Top Gainers

Top Losers